Evolus Inc (EOLS)

$12.75 0.38 (2.89%)

16:00 EDT EOLS Stock Quote Delayed 30 Minutes

EOLS Stock Earnings: Evolus Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings May 7, 2024

EOLS stock results show that Evolus beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

EOLS Stock Earnings: Evolus Misses EPS, Beats Revenue for Q4 2023

7 Must-Own Small-Cap Stocks That Could Outperform the Market

More Articles

Volume:

Previous Close -

Market Cap 695.85M

PE Ratio -12.26

EPS -1.04

Volume (Avg. Vol.) 423,435

Day's Range $12.51 - $13.05

52-Week Range $7.07 - $15.43

Dividend & Yield N/A (N/A)

EOLS Stock Predictions, Articles, and Evolus Inc News

From InvestorPlace
From the Web

7 Small-Cap Stocks Analysts Predict Will Double in 2024

By Josh Enomoto, InvestorPlace Contributor Sep 13, 2023

While small-cap stocks to buy present exceptional risk, they also offer tremendous rewards for intrepid retail investors.

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Thursday Morning

By William White, InvestorPlace Writer Apr 22, 2021

Thursday's here and we're taking a look at the biggest pre-market movers investors will want to know about before the opening bell.

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Thursday Morning

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Mar 25, 2021

Pre-market movers this morning include some high-profile top gainers and losers. Take a look at this list that includes NFT stocks and EV plays.

EOLS Stock: The Big News That Has Evolus Shares Skyrocketing Today

By William White, InvestorPlace Writer Feb 19, 2021

Evolus (EOLS) stock was on the rise Friday following news that it's no longer dealing with lawsuits from AbbVie (ABBV) and Medytox.

Evolus, Alvotech gain as Barclays raises to Ovrweight (NASDAQ:ALVO)

From Seeking Alpha Jan 29, 2024

Barclays upgrades Evolus (EOLS) and Alvotech (ALVO), leading to a run-up in their share prices. Find out reasons behind the upgrade.

Evolus shares rise on upbeat 2024 revenue outlook (NASDAQ:EOLS)

From Seeking Alpha Jan 16, 2024

Evolus (EOLS) reported strong Q4 revenue with a 40% YoY increase, leading to a 5.5% jump in after-hours trading.

AbbVie sees maintaining Botox position in aesthetics: report (NYSE:ABBV)

From Seeking Alpha Jan 10, 2024

Despite increasing competition, AbbVie reportedly expects Botox to maintain its leading market share position in the aesthetics market. Read more here.

Why Shares of Evolus Are Jumping Thursday

From The Motley Fool Jul 27, 2023

The stock climbed on record second-quarter revenue and a raise in full-year guidance.

Why Evolus Shares Jumped This Week

From The Motley Fool Jan 20, 2023

The company said it expects to turn a profit in the fourth quarter.

SVB Securities Sticks to Its Buy Rating for Evolus (EOLS)

From TipRanks Nov 10, 2022

In a report released yesterday, Marc Goodman from SVB Securities reiterated a Buy rating on Evolus (EOLS – Research Report), with a price target of $18.00. Th...

ADVERTISEMENT